Skip to content
Recall Observatory FDA recall evidence

Drug product

dilTIAZem HCl 125 mg per 125 mL (1 mg per mL) in 0.7% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-976-01.

D-0302-2022

November 12, 2021

Class II

Product summary

Firm
SterRx, LLC
Event
Event 89059
Status
Terminated
Classification
Class II
Quantity
24300 bags
Official record key
drug-enforcement:D-0302-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lots S21164/BTV, 3-Dec-21; S21191/BUU, 18-DEC-21; S21197/BUZ, 31-Dec-21; S21220/BVV, 13-Jan-22; S21271/BX0, 27-Jan-22; S21272/BXP, 28-Jan-22; S21299/BYP, 18-Fev-22; S21300/BYQ, 19-Feb-22

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility